Skip to main content
Stem Cells Translational Medicine logoLink to Stem Cells Translational Medicine
. 2015 Aug 18;5(6):845. doi: 10.5966/sctm.2015-0021erratum

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome

Oscar E Simonson, Dimitrios Mougiakakos, Nina Heldring, Giulio Bassi, Henrik J Johansson, Magnus Dalén, Regina Jitschin, Sergey Rodin, Matthias Corbascio, Samir El Andaloussi, Oscar PB Wiklander, Joel Z Nordin, Johan Skog, Charlotte Romain, Tina Koestler, Laila Hellgren-Johansson, Petter Schiller, Per-Olof Joachimsson, Hans Hägglund, Mattias Mattsson, Janne Lehtiö, Omid R Faridani, Rickard Sandberg, Olle Korsgren, Mauro Krampera, Daniel J Weiss, Karl-Henrik Grinnemo, Katarina Le Blanc
PMCID: PMC4878323  PMID: 27221332

Stem Cells Translational Medicine 2015;4:1199–1213; first published on August 18, 2015; http://dx.doi:10.5966/sctm.2015-0021

In the Materials and Methods section, the Ethical Considerations paragraph incorrectly noted the regulatory permit approval numbers for this study. The first sentence of the paragraph should have stated the following:

The production of clinical-grade MSCs was accredited by the Swedish National Board of Health and Welfare (approval numbers 6.3.3-8874-2011 and 6.1.3-9791/2013).

The authors regret the error, which has been corrected in the online version of the article.


Articles from Stem Cells Translational Medicine are provided here courtesy of Oxford University Press

RESOURCES